Court ruling stalls CDC vaccine guidance, leaving doctors and families uncertain

Millions of Americans could head into the fall respiratory season without timely guidance on COVID shots and updated flu vaccines, a policy freeze that threatens the doctors, pharmacies, insurers and nursing homes that rely on federal recommendations to steer care and coverage.

The immediate problem is not just legal, it is operational. A Boston-based federal judge, Brian Murphy, put the Advisory Committee on Immunization Practices on hold after finding that most of the members appointed last year by Health Secretary Robert F. Kennedy Jr. were unqualified. That ruling left the Centers for Disease Control and Prevention without a functioning vaccine advisory body at the very moment when pediatricians, pharmacists, long-term care facilities and health plans normally look for new guidance on seasonal shots and any updated use for existing vaccines.

Former CDC official Demetre Daskalakis summed up the uncertainty in three words: “It’s just uncharted territory.” Vanderbilt infectious-disease physician William Schaffner warned that without ACIP recommendations, newly licensed vaccines and expanded indications may still be legal to prescribe, but insurers and federal programs may not have to cover them.

The stakes reach far beyond whether a doctor can write a prescription. ACIP recommendations become official CDC policy only after adoption by the CDC director, and those recommendations underpin the CDC’s adult and childhood immunization schedules as well as many coverage decisions. The court’s March 16, 2026 preliminary injunction stayed all votes taken by the then-stayed committee and also paused the heavily revised vaccine schedule HHS issued on January 5, 2026, including reversals related to COVID-19 and hepatitis B recommendations.

Insurance coverage is the immediate pressure point. AHIP said its member health plans would continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated COVID-19 and influenza vaccines, with no cost-sharing through the end of 2026. But KFF said Kennedy-era changes had already affected seven vaccine recommendations: meningococcal, RSV for adults, RSV for children, influenza, COVID-19, MMRV and hepatitis B. KFF also noted that states cannot impose vaccine coverage requirements on self-insured employer plans, which cover most employer-sponsored insurance.

The fight now collides with the calendar. ACIP’s charter was renewed through April 1, 2028, and a Federal Register notice said the committee should consider vaccine use at its next regularly scheduled meeting after licensure or authorization of a new vaccine or indication. CDC’s meeting calendar lists sessions for June 24-25, 2026, and October 21-22, 2026, the kind of timetable that could be thrown into confusion if the panel remains frozen.

The broader split is already visible. The American Academy of Pediatrics has published a 2026 childhood and adolescent immunization schedule that differs from CDC’s most recent approach, while the American Medical Association says it continues to support evidence-based immunizations and issued a statement on the court ruling. The plaintiffs in the case included the American Academy of Pediatrics, the American Public Health Association, the American College of Physicians, the Infectious Diseases Society of America, the Society for Maternal-Fetal Medicine, the Massachusetts Chapter of the AAP, the Massachusetts Public Health Alliance and Jane Does 1, 2 and 3.